These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 19723499)

  • 21. Sinusoidal Electromagnetic Fields Increase Peak Bone Mass in Rats by Activating Wnt10b/β-Catenin in Primary Cilia of Osteoblasts.
    Zhou J; Gao YH; Zhu BY; Shao JL; Ma HP; Xian CJ; Chen KM
    J Bone Miner Res; 2019 Jul; 34(7):1336-1351. PubMed ID: 30779853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of continuous activation of vitamin D and Wnt response pathways on osteoblastic proliferation and differentiation.
    Shi YC; Worton L; Esteban L; Baldock P; Fong C; Eisman JA; Gardiner EM
    Bone; 2007 Jul; 41(1):87-96. PubMed ID: 17513186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Essential role of nuclear factor of activated T cells (NFAT)-mediated Wnt signaling in osteoblast differentiation induced by strontium ranelate.
    Fromigué O; Haÿ E; Barbara A; Marie PJ
    J Biol Chem; 2010 Aug; 285(33):25251-8. PubMed ID: 20554534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preactivation of β-catenin in osteoblasts improves the osteoanabolic effect of PTH in type 1 diabetic mice.
    Chen S; Yang L; He S; Yang J; Liu D; Bao Q; Qin H; Du W; Zhong X; Chen C; Zong Z
    J Cell Physiol; 2020 Feb; 235(2):1480-1493. PubMed ID: 31301073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of Gsα in the Postnatal Skeleton Leads to Low Bone Mass and a Blunted Response to Anabolic Parathyroid Hormone Therapy.
    Sinha P; Aarnisalo P; Chubb R; Poulton IJ; Guo J; Nachtrab G; Kimura T; Swami S; Saeed H; Chen M; Weinstein LS; Schipani E; Sims NA; Kronenberg HM; Wu JY
    J Biol Chem; 2016 Jan; 291(4):1631-1642. PubMed ID: 26598522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
    Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
    Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CTLA-4Ig (abatacept) balances bone anabolic effects of T cells and Wnt-10b with antianabolic effects of osteoblastic sclerostin.
    Roser-Page S; Vikulina T; Weiss D; Habib MM; Beck GR; Pacifici R; Lane TF; Weitzmann MN
    Ann N Y Acad Sci; 2018 Mar; 1415(1):21-33. PubMed ID: 29500936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT.
    Almeida M; Han L; Bellido T; Manolagas SC; Kousteni S
    J Biol Chem; 2005 Dec; 280(50):41342-51. PubMed ID: 16251184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Parathyroid hormone and Wnt signaling].
    Tamura Y; Kaji H
    Clin Calcium; 2013 Jun; 23(6):847-52. PubMed ID: 23719497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Smad3, acting independently of transforming growth factor-beta, in the early induction of Wnt-beta-catenin signaling by parathyroid hormone in mouse osteoblastic cells.
    Inoue Y; Canaff L; Hendy GN; Hisa I; Sugimoto T; Chihara K; Kaji H
    J Cell Biochem; 2009 Sep; 108(1):285-94. PubMed ID: 19582775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anabolic effects of intermittent PTH on osteoblasts.
    Greenfield EM
    Curr Mol Pharmacol; 2012 Jun; 5(2):127-34. PubMed ID: 21787293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of osteoblastogenesis and bone mass by Wnt10b.
    Bennett CN; Longo KA; Wright WS; Suva LJ; Lane TF; Hankenson KD; MacDougald OA
    Proc Natl Acad Sci U S A; 2005 Mar; 102(9):3324-9. PubMed ID: 15728361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose PTH increases osteoblast activity via decreased Mef2c/Sost in senescent osteopenic mice.
    Saidak Z; Le Henaff C; Azzi S; Marty C; Marie PJ
    J Endocrinol; 2014 Oct; 223(1):25-33. PubMed ID: 25056116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parathyroid hormone-dependent signaling pathways regulating genes in bone cells.
    Swarthout JT; D'Alonzo RC; Selvamurugan N; Partridge NC
    Gene; 2002 Jan; 282(1-2):1-17. PubMed ID: 11814673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic Effect of Calcimimetics on Osteoclast-Osteoblast Crosslink in Chronic Kidney Disease and Mineral Bone Disease.
    Hung KC; Chang JF; Hsu YH; Hsieh CY; Wu MS; Wu MY; Chiu IJ; Syu RS; Wang TM; Wu CC; Hung LY; Zheng CM; Lu KC
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice.
    Weinstein RS; Jilka RL; Almeida M; Roberson PK; Manolagas SC
    Endocrinology; 2010 Jun; 151(6):2641-9. PubMed ID: 20410195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of cyclin-dependent kinase 1 impairs bone formation, but does not affect the bone-anabolic effects of parathyroid hormone.
    Takahashi A; Mulati M; Saito M; Numata H; Kobayashi Y; Ochi H; Sato S; Kaldis P; Okawa A; Inose H
    J Biol Chem; 2018 Dec; 293(50):19387-19399. PubMed ID: 30366983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects.
    Yao W; Cheng Z; Shahnazari M; Dai W; Johnson ML; Lane NE
    J Bone Miner Res; 2010 Feb; 25(2):190-9. PubMed ID: 19594295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Notch Ligand Jagged1 Regulates the Osteoblastic Lineage by Maintaining the Osteoprogenitor Pool.
    Lawal RA; Zhou X; Batey K; Hoffman CM; Georger MA; Radtke F; Hilton MJ; Xing L; Frisch BJ; Calvi LM
    J Bone Miner Res; 2017 Jun; 32(6):1320-1331. PubMed ID: 28277610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of Wnt/beta-catenin signaling increases insulin sensitivity through a reciprocal regulation of Wnt10b and SREBP-1c in skeletal muscle cells.
    Abiola M; Favier M; Christodoulou-Vafeiadou E; Pichard AL; Martelly I; Guillet-Deniau I
    PLoS One; 2009 Dec; 4(12):e8509. PubMed ID: 20041157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.